TY - JOUR
T1 - Influence of lung function and sleep-disordered breathing on all-cause mortality
T2 - A community-based study
AU - Putcha, Nirupama
AU - Crainiceanu, Ciprian
AU - Norato, Gina
AU - Samet, Jonathan
AU - Quan, Stuart F.
AU - Gottlieb, Daniel J.
AU - Redline, Susan
AU - Punjabi, Naresh M.
N1 - Funding Information:
The Sleep Heart Health Study was supported by NHLBI cooperative agreements U01HL53940 (University of Washington), U01HL53941 (Boston University), U01HL53938 (University of Arizona), U01HL53916 (University of California, Davis), U01HL53934 (University of Minnesota), U01HL53931 (New York University), U01HL53937 and U01HL64360 (Johns Hopkins University), U01HL63463 (Case Western Reserve University), and U01HL63429 (Missouri Breaks Research). N.P. is supported by National Institutes of Health grant K23-HL123594 and the Johns Hopkins University School of Medicine Clinician Scientist Award. N.M.P. is supported by National Institutes of Health grants R01 HL075078 and R01 HL117167.
Publisher Copyright:
© Copyright 2016 by the American Thoracic Society.
PY - 2016/10/15
Y1 - 2016/10/15
N2 - Rationale: Whether sleep-disordered breathing (SDB) severity and diminished lung function act synergistically to heighten the risk of adverse health outcomes remains a topic of significant debate. Objectives: The current study sought to determine whether the association between lower lung function and mortality would be stronger in those with increasing severity of SDB in a communitybased cohort of middle-aged and older adults. Methods: Full montage home sleep testing and spirometry data were analyzed on 6,173 participants of the Sleep Heart Health Study. Proportional hazards models were used to calculate risk for all-cause mortality, with FEV1 and apnea-hypopnea index (AHI) as the primary exposure indicators along with several potential confounders. Measurements and Main Results: All-cause mortality rate was 26.9 per 1,000 person-years in those withSDB(AHI≥5 events/h) and 18.2 per 1,000 person-years in those without (AHI<5 events/h). For every 200-ml decrease in FEV1, all-cause mortality increased by 11.0% in those without SDB (hazard ratio, 1.11; 95% confidence interval, 1.08-1.13). In contrast, for every 200-ml decrease in FEV1, all-cause mortality increased by only 6.0% in participants with SDB (hazard ratio, 1.06;95% confidence interval, 1.04-1.09). Additionally, the incremental influence of lung function on all-cause mortality was less with increasing severity of SDB (P value for interaction between AHI and FEV1, 0.004). Conclusions: Lung function was associated with risk for all-cause mortality. The incremental contribution of lung function to mortality diminishes with increasing severity of SDB.
AB - Rationale: Whether sleep-disordered breathing (SDB) severity and diminished lung function act synergistically to heighten the risk of adverse health outcomes remains a topic of significant debate. Objectives: The current study sought to determine whether the association between lower lung function and mortality would be stronger in those with increasing severity of SDB in a communitybased cohort of middle-aged and older adults. Methods: Full montage home sleep testing and spirometry data were analyzed on 6,173 participants of the Sleep Heart Health Study. Proportional hazards models were used to calculate risk for all-cause mortality, with FEV1 and apnea-hypopnea index (AHI) as the primary exposure indicators along with several potential confounders. Measurements and Main Results: All-cause mortality rate was 26.9 per 1,000 person-years in those withSDB(AHI≥5 events/h) and 18.2 per 1,000 person-years in those without (AHI<5 events/h). For every 200-ml decrease in FEV1, all-cause mortality increased by 11.0% in those without SDB (hazard ratio, 1.11; 95% confidence interval, 1.08-1.13). In contrast, for every 200-ml decrease in FEV1, all-cause mortality increased by only 6.0% in participants with SDB (hazard ratio, 1.06;95% confidence interval, 1.04-1.09). Additionally, the incremental influence of lung function on all-cause mortality was less with increasing severity of SDB (P value for interaction between AHI and FEV1, 0.004). Conclusions: Lung function was associated with risk for all-cause mortality. The incremental contribution of lung function to mortality diminishes with increasing severity of SDB.
KW - Impaired lung function
KW - Mortality
KW - Sleep apnea
UR - http://www.scopus.com/inward/record.url?scp=84989322411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84989322411&partnerID=8YFLogxK
U2 - 10.1164/rccm.201511-2178OC
DO - 10.1164/rccm.201511-2178OC
M3 - Article
C2 - 27105053
AN - SCOPUS:84989322411
SN - 1073-449X
VL - 194
SP - 1007
EP - 1014
JO - American journal of respiratory and critical care medicine
JF - American journal of respiratory and critical care medicine
IS - 8
ER -